Ubs Group Ag Sop Hi A Genetics Sa Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Ubs Group Ag holds 7,947 shares of SOPH stock, worth $23,841. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,947

Previous 38,553 79.39%

Holding current value

$23,841

Previous $118,000 77.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$2.89 - $4.5 $88,451 - $137,727	-30,606 Reduced 79.39%	7,947 $26,000
Q4 2024 Feb 14, 2025	BUY	$3.07 - $3.99 $94,503 - $122,824	30,783 Added 396.18%	38,553 $118,000
Q2 2024 Aug 13, 2024	SELL	$4.46 - $5.55 $905 - $1,126	-203 Reduced 2.55%	7,770 $35,000
Q4 2023 Feb 09, 2024	SELL	$2.5 - $4.87 $6,867 - $13,377	-2,747 Reduced 25.62%	7,973 $37,000
Q3 2023 Nov 09, 2023	BUY	$2.3 - $4.58 $482 - $961	210 Added 2.0%	10,720 $27,000
Q2 2023 Aug 11, 2023	SELL	$3.84 - $5.3 $16,296 - $22,493	-4,244 Reduced 28.77%	10,510 $47,000
Q1 2023 May 12, 2023	SELL	$1.98 - $5.49 $6,395 - $17,732	-3,230 Reduced 17.96%	14,754 $73,000
Q4 2022 Feb 08, 2023	SELL	$1.71 - $2.98 $47,437 - $82,668	-27,741 Reduced 60.67%	17,984 $37,000
Q3 2022 Nov 10, 2022	SELL	$2.63 - $5.1 $86 - $168	-33 Reduced 0.07%	45,725 $120,000
Q2 2022 Aug 10, 2022	BUY	$2.46 - $7.91 $68,142 - $219,107	27,700 Added 153.39%	45,758 $165,000
Q1 2022 May 16, 2022	BUY	$7.31 - $15.6 $321 - $686	44 Added 0.24%	18,058 $140,000
Q4 2021 Feb 14, 2022	BUY	$12.35 - $18.8 $90,871 - $138,330	7,358 Added 69.05%	18,014 $254,000
Q3 2021 Nov 15, 2021	BUY	$15.18 - $19.77 $161,758 - $210,669	10,656 New	10,656 $187,000

Others Institutions Holding SOPH

# of Institutions

Shares Held

25.5M

Call Options Held

500

Put Options Held

3.8K

View Full List

About SOPHiA GENETICS SA

Ticker SOPH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 64,153,700
Market Cap $192M
Description
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...

More about SOPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account